Holen Sie sich die Stockscreener-App
1.07
6.14%
-0.07
Handel nachbörslich:
.97
-0.10
-9.35%
Schlusskurs vom Vortag:
$1.14
Offen:
$1.13
24-Stunden-Volumen:
23,154
Relative Volume:
0.16
Marktkapitalisierung:
$6.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.83%
1M Leistung:
-12.30%
6M Leistung:
-72.49%
1J Leistung:
-77.23%
1-Tages-Spanne:
$1.06
$1.13
1-Wochen-Bereich:
$1.0501
$1.15
52-Wochen-Spanne:
$0.8563
$5.88
Callan Jmb Inc Stock (CJMB) Company Profile
Firmenname
Callan Jmb Inc
Sektor
Telefon
(830) 438-0395
Adresse
244 FLIGHTLINE DRIVE, SPRING BRANCH
Compare CJMB vs FDX, UPS, JBHT, EXPD, CHRW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CJMB
Callan Jmb Inc
|
1.07 | 6.42M | 0 | 0 | 0 | 0.00 |
FDX
Fedex Corp
|
378.90 | 90.33B | 91.93B | 4.48B | 4.37B | 18.79 |
UPS
United Parcel Service Inc
|
100.00 | 85.66B | 88.37B | 5.25B | 4.52B | 6.1769 |
JBHT
J B Hunt Transport Services Inc
|
240.75 | 23.14B | 12.13B | 622.10M | 1.03B | 6.4596 |
EXPD
Expeditors International Of Washington Inc
|
155.54 | 20.49B | 11.19B | 837.99M | 953.40M | 4.4773 |
CHRW
C H Robinson Worldwide Inc
|
169.98 | 20.20B | 16.20B | 599.01M | 807.11M | 4.9401 |
Callan Jmb Inc Aktie (CJMB) Neueste Nachrichten
CJMB Q4 Earnings: Callan JMB Posts No Formal Guidance Amid UncertaintyRetail Trader Ideas - newser.com
CJMB (Callan JMB) outlines strategic operational upgrades to boost multi-segment revenue growth over coming quarters.Operating Income - newser.com
Callan JMB (CJMB) Stock: Why Revenue Growth (Institutional Demand) 2026-04-22Hedge Fund Inspired Picks - newser.com
CJMB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Callan JMB Inc. plans 150-acre campus in Marion - Business Alabama Magazine
Callan JMB plans 150-acre pharmaceutical campus in Alabama By Investing.com - Investing.com India
Callan JMB plans 150-acre pharmaceutical campus in Alabama - Investing.com
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC - marketscreener.com
Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure - The Manila Times
Callan JMB Launches The Atlas Complex in Alabama to - GlobeNewswire
Callan JMB faces patent infringement lawsuit in Texas By Investing.com - Investing.com Australia
Callan JMB faces patent infringement lawsuit in Texas - Investing.com
Callan JMB Inc. Responds to Lawsuit Filed by Eddie Patent Holdings, LLC - Quiver Quantitative
Callan Jmb Complaint Filed By Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, Or Ongoing Projects - TradingView
Investment Report: What drives Callan JMB Incs stock price2026 Closing Moves & Reliable Price Breakout Signals - baoquankhu1.vn
Earnings Miss: Is Callan JMB Inc stock a buy or sell2026 Intraday Action & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Callan JMB Inc. Files Form 8-K with SEC: Company Details, Address, and NASDAQ Listing Information - Minichart
Callan JMB Receives Nasdaq Deficiency Notice on Equity - TipRanks
Callan JMB Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Growth Report: Is Callan JMB Inc forming a bullish divergence2026 Winners & Losers & Technical Pattern Alert System - baoquankhu1.vn
Is Callan JMB (CJMB) Stock defensive in downturns | Price at $1.19, Down 1.65%Social Trade Signals - newser.com
Aug Update: Does Callan JMB Inc align with a passive investing strategy2026 Outlook & Verified Swing Trading Watchlists - baoquankhu1.vn
Is Callan JMB (CJMB) Stock Moving Higher | Price at $1.29, Down 1.53%ATR Levels - newser.com
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer - Sahm
Callan JMB Accelerates Cross-Jurisdiction Vaccine Redistribution to Combat Localized Outbreaks - Healthcare Packaging
Aug Momentum: What drives Callan JMB Incs stock priceMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Callan JMB Successfully Deploys Rapid Redistribution of - GlobeNewswire
New Highs: Is Xylem Inc in a long term uptrend2026 Top Decliners & AI Driven Stock Movement Reports - baoquankhu1.vn
Callan Jmb (CJMB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
CJMB Stock Analysis: Callan JMB Inc. 7.26 Percent Gain to 1.33, Key Drivers Breakdown - Cổng thông tin điện tử tỉnh Lào Cai
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update - The Manila Times
EV Market: What drives Callan JMB Incs stock priceIPO Watch & Verified Technical Signals - baoquankhu1.vn
Callan JMB to oversee manufacturing for JKB-122 immune platform By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Friday's Intraday Session - Benzinga
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement - globenewswire.com
Top Executive Makes Bold Insider Move at Callan JMB, Inc. - TipRanks
Croyle David J, chief medical officer, buys $17841 in Callan JMB Inc. - Investing.com UK
Market Review: What drives Callan JMB Incs stock price2026 Rallies & Fast Moving Stock Trade Plans - baoquankhu1.vn
Volume Summary: Does Callan JMB Inc align with a passive investing strategy - baoquankhu1.vn
Callan JMB files to sell 6M shares of common stock for holders - MSN
Callan JMB Amends Equity Purchase Agreement with Hexstone - The Globe and Mail
Callan JMB to oversee manufacturing for Long COVID drug trial By Investing.com - Investing.com South Africa
Callan JMB to oversee manufacturing for Long COVID drug trial - Investing.com
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech's IND Clinical Trials for lodonal in the Treatment of Long COVID - Bitget
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID - The Globe and Mail
Croyle David J, chief medical officer, buys Callan JMB (CJMB) shares - Investing.com UK
Finanzdaten der Callan Jmb Inc-Aktie (CJMB)
Es liegen keine Finanzdaten für Callan Jmb Inc (CJMB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
2.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):